期刊文献+

心肺转流期间尼克酰胺磷酸核糖转移酶的变化及其与糖代谢的相关性分析

The variance of Nicotinamide phosphoribosyltransferase(NAMPT)during CPB and its correlation with glucose metabolism
下载PDF
导出
摘要 目的探讨心肺转流(CPB)期间尼克酰胺磷酸核糖转移酶(NAMPT)水平的变化及其与糖代谢的关系。方法择期心瓣膜置换术患者36例,于麻醉后5min(T1)、阻断主动脉后5min(T2)、复温后5min(T3)、开放主动脉后5min(T4)、术毕后5min(T5)从中心静脉抽取血标本,检测血清NAMPT、胰岛素水平和全血血糖水平并计算胰岛素抵抗指数(HOMA-IR),分析NAMPT水平的变化及其与糖代谢的关系。结果与T1时比较,T2~T5时患者血清NAMPT、血清胰岛素、血糖和HOMA-IR均明显升高(P〈0.05),且均在L时达到峰值。血清胰岛素水平与NAMPT具有显著正相关(r=0.873,P〈0.01)。结论心瓣膜置换术CPB期间NAMPT和胰岛素的变化具有正相关性,NAMPT可能参与了糖代谢。 Objective To investigate the variance of serum Nicotinamide phosphoribosyltrans- ferase (NAMPT) level during CPB and its relevance to glucose metabolisrrL Methods Thirty-six pa- tients for elective heart valve replacement surgery were enrolled in this study. The blood samples were collected 5 min after anesthesia (T1), 5 rain after aortic clamping (T2), 5 min after rewarming (73), 5 min after aortic clamp releasing (T4) and 5 min after the end of operation (T5). Serum levels of NAMPT, insulin and blood glucose were detected, and insulin resistance index was calculated. The correlation between serum NAMPT level and glucose metabolism was then analyzed. Results Compared with T1, serum levels of NAMPT and insulin, blood glucose and insulin resistance index were significantly elevated at T2-T5 (P〈0.05), moreover, the levels were highest at 73. There was a positive correlation between the variance of serum insulin level and NAMPT level(r=0. 873, P〈0. 01). Conclusion The serum NAMPT level is positively correlated with serum insulin level during CPB.
出处 《临床麻醉学杂志》 CAS CSCD 北大核心 2014年第4期356-359,共4页 Journal of Clinical Anesthesiology
基金 卫生部国家临床重点专科建设基金资助项目[财社(2011)170号] 重庆市医学重点学科计划项目[渝卫科教(2007)2号]
关键词 心肺转流 尼克酰胺磷酸核糖转移酶 胰岛素抵抗 血糖 Cardiopulmonary bypass Nicotinamide phosphoribosyltransferase Insulin resistance Blood glucose
  • 相关文献

参考文献12

  • 1Doenst T, Wijeysundera D, Karkouti K, eta|. Hyperglyce- mia during cardiopulmonary bypass is an independent risk fac- tor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg, 2005,130(4) : 1144.
  • 2Chang YH, Chang DM, Lin KC, et al. Visfatin in over- weight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a recta-anal- ysis and systemic review. Diabetes Metab Res Rev, 2011,27 (6) :515-527.
  • 3Fasshauer M, Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia, 2003,46(12) : 1594-1603.
  • 4Revollo JR, Komer A, Mills KF, et al. NAMtZl'/PBEF/Visfa- tin regulates insulin secretion in beta cells as a systemic NAD bio- synthetic enzyme Cell metabolism, 2007,6 (5) : 363-375.
  • 5El-Mesallamy HO, Kassem DH, E1-Demerdash E, et al. Vaspin and vis{atin/NAMPT are interesting interrelated adi- potdnes playing a role in the patbogeness o type 2 diabetes mellitus. Metabolism, 2011,60(1) 63-70.
  • 6Benedict C, Shostak A, Large T, et al. Diurnal rhythm of circu- lating nicotinamide phosphoribosyltransferase (NAMPT/visfatin/ PBEF) : impact of sleep loss and relation to glucose metabolism. J Clin Endocrinol Metab, 2012,97 (2) : E218-222.
  • 7Sun B, Yang G, Yang M, et al. Long-term high-fat diet links the regulation of the insulin-sensitizing fibroblast growth factor-21 and visfatin. Cytokine,2012,59(1) .- 131-137.
  • 8Sun Q, Li L, Li R, et al. Overexpression of visfatin/PBEF/ NAMPT alters whole-body insulin sensitivity and lipid profile in rats. Ann Med, 2009, 41(4):311-320.
  • 9Agueda M, Lasa A, Simon E, et al. Association of circulat- ing visfatin concentrations with insulin resistance and low- grade inflammation after dietary energy restriction in Spanishobese non-diabetic women: role of body composition changes. Nutr Metab Cardiovasc Dis, 2012, 22(3):208-214.
  • 10Caton PW, Kieswich J, Yaqoob MM, et al. Nicotinamide mononucleotide protects against pro-inflammatory cytokine- mediated impairment o{ mouse islet function. Diabetologia, 2011,54(12) :3083-3092.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部